We’re here to support researchers. Visit our COVID-19 page for links to emerging research, updates about our policies, and more resources related to the pandemic. View the page

We have updated our Privacy Policy. Read more

Read about our Cookie Policy. Learn more

When you choose to publish with PLOS, your research makes an impact. Make your work accessible to all, without restrictions, and accelerate scientific discovery with options like preprints and published peer review that make your work more Open.

PLOS Pathogens Year in Review

2020 was a year of growth for PLOS Pathogens. We expanded our editorial board and published important research that made an impact in the global Covid-19 conversation. Discover journal updates, a message from the Editors-in-Chief, research highlights, and more.


We added new and noteworthy research to the Antifungal Immunity Collection launched in 2019.

Read 2020 research from the collection


In 2020, PLOS Pathogens articles were referenced an estimated 4,880 times by media outlets around the world. Explore articles that made the news.

Ready to share your study with a wider audience? Help more people read, see, and cite your published research with our Author Media Toolkit

“Looking back on 2020 we want to extend a heartfelt thank you to the PLOS Pathogens community of authors, reviewers and editors, that have volunteered their time and energy to not only maintain excellence, but to grow the journal in what has proven to be a tumultuous year. Together with our wonderful journal staff, we have worked to meet the challenge of quickly disseminating fast-changing research during the SARS-CoV-2 pandemic with a dedicated team of editors who together have handled over 250 COVID-19 submissions. Our newly refreshed team of Reviews Editors have brought an exciting array of Reviews at the forefront of pathogens researchWe decreased our time to first decision and time to publish, and we continue to support open initiatives through partnerships such as Review Commons.

As we move into 2021 we are excited to continue to move
PLOS Pathogens forward with the community by promoting publication in areas that include clinical research as well as the microbiome, refreshing the PLOS Pathogens brand, expanding our Editorial Board globally, and focusing on diversity and inclusion for all contributors.”

Kasturi Haldar

Kasturi Haldar, Editor-in-Chief

Michael Malim

Michael MalimEditor-in-Chief


This year, we introduced our new Editorial Advisory Group to help make sure we are hearing the needs of the communities that make up the journal.

We also officially welcomed Mike Malim as co-Editor-in-Chief in January! You can read the official announcement here.

Michael Malim

In response to the coronavirus pandemic, we created a team of dedicated SARS-CoV-2/COVID19 editors to handle related submissions and make initial decisions quickly.

Read the announcement of our response here

See the current list of SARS-COV-2/COVID-19 editors

Explore PLOS Pathogens research
in the
COVID-19 pandemic (2019-20) collection 

Noteworthy Review Article:
The hallmarks of COVID-19 disease,
by Daolin Tang, Paul Comish, and Rui Kang

Want more updates from PLOS Pathogens?

Ready to share new research in 2021?

Back to top